Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2025 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkor
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to The Report
Fundraising

Orchid Security

Orchid Security Raises $36M in Seed

2023
Founded
50+
Employees
Tel Aviv, Israel
Updated January 14, 2025
2 min read

Quick Facts

Orchid Security Raises $36M in Seed


Orchid Security has successfully raised $36M in a Seed at a $180M valuation led by Team8, Intel Capital.


Company Overview


Orchid Security is a Cybersecurity company headquartered in Tel Aviv, Israel, founded in 2023 with 50+ employees.


Identity-first security orchestration platform using LLMs to manage fragmented identity systems


Fundraising Details


  • Amount Raised: $36M
  • Round Type: Seed
  • Valuation: $180M
  • Date: 2025-01-14
  • Investors: Team8, Intel Capital

About Orchid Security


Identity-first security orchestration platform using LLMs to manage fragmented identity systems The company is positioned in the Cybersecurity sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Tel Aviv, Israel
  • Founded: 2023
  • Team Size: 50+
  • Industry: Cybersecurity

What This Means


This funding round demonstrates strong investor confidence in Orchid Security's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Cybersecurity sector continues to attract significant investment as companies innovate to meet evolving market demands. Orchid Security's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $180M valuation marks an important milestone for Orchid Security, positioning the company among notable players in the Cybersecurity industry.


Looking Ahead


With this new capital, Orchid Security is well-positioned to execute on its growth strategy and continue building innovative solutions in the Cybersecurity space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-01-14. For more information about Orchid Security, visit their headquarters at Tel Aviv, Israel.

Topics

Fundraising(2912)Cybersecurity(452)SeedOrchid Security

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million